|
HY-141510-10mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-100mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-25mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-5mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-50mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-D0166A-5g
|
MedChemexpress LLC
|
Neutral Red (IND) [CAS 553-24-2]
|
|
|
|
|
HY-106934A-10mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-100mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-5mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-50mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-1mL
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-106934-10mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-100mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-5mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-50mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-1mL
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-D1451-1mg
|
MedChemexpress LLC
|
PKH 26 [CAS 154214-55-8]
|
|
|
|
|
HY-D1451-10mg
|
MedChemexpress LLC
|
PKH 26 [CAS 154214-55-8]
|
|
|
|
|
HY-D1451-5mg
|
MedChemexpress LLC
|
PKH 26 [CAS 154214-55-8]
|
|
|
|
|
HY-D1421
|
MedChemexpress LLC
|
PKH 67 [CAS 257277-27-3]
|
|
|
|
|
HY-100711-1mg
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100711-10mg
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100711-100ug
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100711-250ug
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100711-5mg
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
